GlassScriptPhysician profile
Eun J Shin
NPI 1558423210
$69,898.32
in general payments reported to CMS, 2019-2025
18 companies · $24K in 2025
The $24K reported for 2025 was more than what 95% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $235 · 2021: $6,377 · 2022: $14K · 2023: $10K · 2024: $4,253 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Consulting Fee: $8,500 · Food and Beverage: $4,623 · Travel and Lodging: $4,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,750.00 |
| Consulting Fee | $8,500.00 |
| Food and Beverage | $4,622.51 |
| Travel and Lodging | $4,127.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $65,346.56 | 2019-2025 | General - Therapies, Wallflex Duodenal, Axios |
| Pentax of America, INC. | $1,345.45 | 2019-2025 | Pentax Medical, C2 Cryoballoon, Inspira |
| Medtronic, INC. | $1,017.14 | 2021-2024 | Nexpowder, Endoflip, Gi Genius |
| Laborie Medical Technologies Corp. | $475.52 | 2023-2025 | Alphaone |
| Fujifilm Healthcare Americas Corporation | $447.90 | 2023-2025 | Fujifilm |
| Conmed Corporation | $316.13 | 2021 | |
| Olympus America INC. | $251.34 | 2019-2024 | Visiglide |
| Covidien LP | $237.30 | 2019-2020 | |
| Erbe USA INC | $176.00 | 2024-2025 | Erbe |
| Cook Medical LLC | $115.89 | 2021 | |
| Qol Medical, LLC | $46.92 | 2025 | Sucraid |
| Ambu INC. | $23.19 | 2021 | |
| Madrigal Pharmaceuticals | $21.47 | 2025 | Rezdiffra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.23 | 2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $16.06 | 2024 | Voquezna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $14.40 | 2024 | Ibsrela |
| Philips North America LLC | $14.00 | 2020 | |
| Novo Nordisk INC | $13.82 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eun Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.